Filgrastim or Pegfilgrastim in Preventing Neutropenia in Women Receiving Chemotherapy Following Surgery for Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Kirsten Murray
Scottish Cancer Therapy Network
Study Chair - Robert C.F. Leonard, MD, BS, MB
Charing Cross Hospital
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
32 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- City Hospital - Birmingham
Birmingham, England, United Kingdom
- Sussex Cancer Centre at Royal Sussex County Hospital
Brighton, England, United Kingdom
- Cheltenham General Hospital
Cheltenham, England, United Kingdom
- Princess Alexandra Hospital
Essex, England, United Kingdom
- St. Luke'S Cancer Centre at Royal Surrey County Hospital
Guildford, England, United Kingdom
- King George Hospital
Ilford, Essex, England, United Kingdom
- Leeds Cancer Centre at St. James'S University Hospital
Leeds, England, United Kingdom
- King'S College Hospital
London, England, United Kingdom
- Queen Elizabeth Hospital Nhs Trust
London, England, United Kingdom
- St. George'S Hospital
London, England, United Kingdom
- Christie Hospital Nhs Trust
Manchester, England, United Kingdom
- Clatterbridge Centre for Oncology Nhs Trust
Merseyside, England, United Kingdom
- Northampton General Hospital Nhs Trust
Northampton, England, United Kingdom
- Norfolk and Norwich University Hospital
Norwich, England, United Kingdom
- Nottingham City Hospital Nhs Trust
Nottingham, England, United Kingdom
- Royal Oldham Hospital
Oldham, England, United Kingdom
- Peterborough Hospitals Trust
Peterborough, England, United Kingdom
- Berkshire Cancer Centre at Royal Berkshire Hospital
Reading, England, United Kingdom
- Oldchurch Hospital
Romford, England, United Kingdom
- Salisbury District Hospital
Salisbury, England, United Kingdom
- Cancer Research Centre at Weston Park Hospital
Sheffield, England, United Kingdom
- South Tyneside District Hospital
South Shields, England, United Kingdom
- Southampton University Hospital Nhs Trust
Southampton, England, United Kingdom
- Sunderland Royal Hospital
Sunderland, England, United Kingdom
- Southend University Hospital Nhs Foundation Trust
Westcliff-on-Sea, England, United Kingdom
- Yeovil District Hospital
Yeovil - Somerset, England, United Kingdom
- Ninewells Hospital and Medical School
Dundee, Scotland, United Kingdom
- Scottish Cancer Therapy Network
Edinburgh, Scotland, United Kingdom
- Royal Infirmary - Castle
Glasgow, Scotland, United Kingdom
- West of Scotland Cancer Centre
Glasgow, Scotland, United Kingdom
- Raigmore Hospital
Inverness, Scotland, United Kingdom
- Singleton Hospital of the Swansea Nhs Trust
Swansea, Wales, United Kingdom
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2001
- Primary completion
- —
- Completion
- —
- Last update posted
- 7 Aug 2013
- Registered enrollment
- 816
- Registry id
- NCT00030758
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.